← Leaderboards
Howard D Strickler
Yeshiva University
$24,187,784
Attributed
$27,218,410
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$27,218,410 · 13
By mechanism
R01$23,326,281 · 7
U01$2,801,893 · 1
R56$480,014 · 1
R21$401,722 · 1
R03$130,507 · 1
P30$77,993 · 2
Top collaborators
- Robert D. Burk11 shared
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanHuman PapillomavirusCohortCervicalOncogenicMalignant NeoplasmsMalignant Neoplasm Of Cervix UteriSpecimenViralInfectionNatural HistoryHuman Papilloma Virus InfectionRisk FactorsDetectionLesionInvestigationProspectiveUnited States National Institutes Of HealthReportingScreeningCervical Intraepithelial NeoplasiaAffectCervical Cancer ScreeningProspective Studies
Grant awards (52)
Investigations Into The Molecular Pathogenesis Of Cervical Glandular Neoplasias$516,029
U01 · FY2024 · CA
Investigations Into The Molecular Pathogenesis Of Cervical Glandular Neoplasias$571,572
U01 · FY2023 · CA
Next Generation of HPV and Cervical Cancer Research in HIV+ Women$655,774
R01 · FY2022 · CA · contact PI
Investigations Into The Molecular Pathogenesis Of Cervical Glandular Neoplasias$571,574
U01 · FY2022 · CA
Next Generation of HPV and Cervical Cancer Research in HIV+ Women$655,774
R01 · FY2021 · CA · contact PI
Investigations Into The Molecular Pathogenesis Of Cervical Glandular Neoplasias$583,239
U01 · FY2021 · CA
Cancer Epidemiology, Prevention & Control$24,001
P30 · FY2021 · CA · contact PI
Next Generation of HPV and Cervical Cancer Research in HIV+ Women$648,844
R01 · FY2020 · CA · contact PI
Investigations Into The Molecular Pathogenesis Of Cervical Glandular Neoplasias$559,479
U01 · FY2020 · CA
Cancer Epidemiology, Prevention & Control$26,996
P30 · FY2020 · CA · contact PI
Next Generation of HPV and Cervical Cancer Research in HIV+ Women$628,673
R01 · FY2019 · CA · contact PI
Cancer Epidemiology, Prevention & Control$26,996
P30 · FY2019 · CA · contact PI
Next Generation of HPV and Cervical Cancer Research in HIV+ Women$349,777
R01 · FY2018 · CA · contact PI
Next Generation of HPV and Cervical Cancer Research in HIV+ Women$320,518
R01 · FY2018 · CA · contact PI
Molecular Methods to Improve Cervical Cancer Screening in HIV+ Women$538,729
R01 · FY2016 · CA · contact PI
Molecular Methods to Improve Cervical Cancer Screening in HIV+ Women$582,135
R01 · FY2015 · CA · contact PI
Molecular Methods to Improve Cervical Cancer Screening in HIV+ Women$67,502
R01 · FY2015 · CA · contact PI
Molecular Methods to Improve Cervical Cancer Screening in HIV+ Women$660,318
R01 · FY2014 · CA · contact PI
HPV & Cervix Neoplasia in a Large, Long Term HIV + Cohort$292,032
R01 · FY2014 · CA · contact PI
HPV & Cervix Neoplasia in a Large, Long Term HIV + Cohort$90,559
R01 · FY2014 · CA · contact PI
Molecular Methods to Improve Cervical Cancer Screening in HIV+ Women$728,869
R01 · FY2013 · CA · contact PI
HPV & Cervix Neoplasia in a Large, Long Term HIV + Cohort$464,272
R01 · FY2013 · CA · contact PI
HPV & Cervix Neoplasia in a Large, Long Term HIV + Cohort$814,047
R01 · FY2012 · CA · contact PI
Role of the Sex Hormones and Insulin/IGF-Axes in Endometrial Cancer Recurrence$395,050
R01 · FY2012 · CA · contact PI
Influence of Fasting Status and Specimen Processing Time on Adipokine Levels$57,016
R03 · FY2012 · CA · contact PI
HPV & Cervix Neoplasia in a Large, Long Term HIV + Cohort$857,594
R01 · FY2011 · CA · contact PI
Role of the Sex Hormones and Insulin/IGF-Axes in Endometrial Cancer Recurrence$482,404
R01 · FY2011 · CA · contact PI
Influence of Fasting Status and Specimen Processing Time on Adipokine Levels$73,491
R03 · FY2011 · CA · contact PI
HPV & Cervix Neoplasia in a Large, Long Term HIV + Cohort$873,650
R01 · FY2010 · CA · contact PI
Role of the insulin/IGF-axis in incident CIN-2+$146,082
R21 · FY2010 · CA · contact PI
Insulin-Like Growth Factor Axis and Type 2 Diabetes$143,418
R01 · FY2010 · DK · contact PI
HPV & cervix neoplasia in a large, long-term HIV+ cohort$692,565
R01 · FY2009 · CA · contact PI
Role of the insulin/IGF-axis in incident CIN-2+$255,640
R21 · FY2009 · CA · contact PI
HPV & cervix neoplasia in a large, long-term HIV+ cohort$676,327
R01 · FY2008 · CA · contact PI
Insulin-like growth factor axis influence on HIV and HPV pathogenesis in women$480,014
R56 · FY2008 · AI · contact PI
HPV & cervix neoplasia in a large, long-term HIV+ cohort$722,808
R01 · FY2007 · CA · contact PI
HPV & cervix neoplasia in a large, long-term HIV+ cohort$723,725
R01 · FY2006 · CA · contact PI
Effects of HLA and KIR genotype on HIV and HCV$489,857
R01 · FY2006 · AI · contact PI
HPV &cervix neoplasia in a large, long-term HIV+ cohort$752,144
R01 · FY2005 · CA
Effects of HLA and KIR genotype on HIV and HCV$614,374
R01 · FY2005 · AI
Insulin and IGF In female colon, breast, uterine cancer$480,595
R01 · FY2005 · CA
HPV &CERVIX NEOPLASIA IN A LARGE, LONG TERM HIV+ COHORT$1,309,031
R01 · FY2004 · CA
Effects of HLA and KIR genotype on HIV and HCV$588,021
R01 · FY2004 · AI
Insulin and IGF In female colon, breast, uterine cancer$572,830
R01 · FY2004 · CA
HPV &CERVIX NEOPLASIA IN A LARGE, LONG TERM HIV+ COHORT$1,271,722
R01 · FY2003 · CA
Insulin and IGF In female colon, breast, uterine cancer$560,767
R01 · FY2003 · CA
Effects of HLA and KIR genotype on HIV and HCV$306,795
R01 · FY2003 · AI
HPV &CERVIX NEOPLASIA IN A LARGE, LONG TERM HIV+ COHORT$700,293
R01 · FY2002 · CA
Insulin and IGF In female colon, breast, uterine cancer$647,877
R01 · FY2002 · CA
HPV &cervix neoplasia in a large, long-term HIV+cohort$552,079
R01 · FY2002 · CA
HPV &CERVIX NEOPLASIA IN A LARGE, LONG TERM HIV+ COHORT$681,365
R01 · FY2001 · CA
HPV &CERVIX NEOPLASIA IN A LARGE, LONG TERM HIV+ COHORT$733,167
R01 · FY2000 · CA